AWH vs. TKNO, VNRX, ABIO, ICCC, OCX, CDIO, TRIB, BMRA, MYMD, and VRAX
Should you be buying Aspira Women's Health stock or one of its competitors? The main competitors of Aspira Women's Health include Alpha Teknova (TKNO), VolitionRx (VNRX), ARCA biopharma (ABIO), ImmuCell (ICCC), OncoCyte (OCX), Cardio Diagnostics (CDIO), Trinity Biotech (TRIB), Biomerica (BMRA), MyMD Pharmaceuticals (MYMD), and Virax Biolabs Group (VRAX). These companies are all part of the "diagnostic substances" industry.
Aspira Women's Health (NASDAQ:AWH) and Alpha Teknova (NASDAQ:TKNO) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, media sentiment, profitability, community ranking, dividends and analyst recommendations.
Alpha Teknova has a net margin of -97.85% compared to Aspira Women's Health's net margin of -163.95%. Alpha Teknova's return on equity of -38.24% beat Aspira Women's Health's return on equity.
Aspira Women's Health received 6 more outperform votes than Alpha Teknova when rated by MarketBeat users. However, 33.33% of users gave Alpha Teknova an outperform vote while only 26.00% of users gave Aspira Women's Health an outperform vote.
12.2% of Aspira Women's Health shares are held by institutional investors. Comparatively, 13.8% of Alpha Teknova shares are held by institutional investors. 4.3% of Aspira Women's Health shares are held by company insiders. Comparatively, 15.2% of Alpha Teknova shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Aspira Women's Health has higher earnings, but lower revenue than Alpha Teknova. Alpha Teknova is trading at a lower price-to-earnings ratio than Aspira Women's Health, indicating that it is currently the more affordable of the two stocks.
In the previous week, Aspira Women's Health had 2 more articles in the media than Alpha Teknova. MarketBeat recorded 2 mentions for Aspira Women's Health and 0 mentions for Alpha Teknova. Alpha Teknova's average media sentiment score of 1.00 beat Aspira Women's Health's score of 0.94 indicating that Alpha Teknova is being referred to more favorably in the news media.
Aspira Women's Health currently has a consensus price target of $4.45, indicating a potential upside of 116.02%. Alpha Teknova has a consensus price target of $15.00, indicating a potential upside of 752.27%. Given Alpha Teknova's higher probable upside, analysts plainly believe Alpha Teknova is more favorable than Aspira Women's Health.
Aspira Women's Health has a beta of 1.5, meaning that its stock price is 50% more volatile than the S&P 500. Comparatively, Alpha Teknova has a beta of 0.39, meaning that its stock price is 61% less volatile than the S&P 500.
Summary
Alpha Teknova beats Aspira Women's Health on 10 of the 17 factors compared between the two stocks.
Get Aspira Women's Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for AWH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AWH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Aspira Women's Health Competitors List
Related Companies and Tools
